Thursday, August 26, 2010

Loprox


Loprox is a brand name of ciclopirox topical, approved by the FDA in the following formulation(s):


LOPROX (ciclopirox - cream; topical)



  • Manufacturer: MEDICIS

    Approval date: December 30, 1982

    Strength(s): 0.77% [RLD][AB]

LOPROX (ciclopirox - gel; topical)



  • Manufacturer: MEDICIS

    Approval date: July 21, 1997

    Strength(s): 0.77% [RLD][AB]

LOPROX (ciclopirox - shampoo; topical)



  • Manufacturer: MEDICIS

    Approval date: February 28, 2003

    Strength(s): 1% [RLD][AT]

LOPROX (ciclopirox - suspension; topical)



  • Manufacturer: MEDICIS

    Approval date: December 30, 1988

    Strength(s): 0.77% [RLD][AB]

Has a generic version of Loprox been approved?


A generic version of Loprox has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Loprox and have been approved by the FDA:


ciclopirox cream; topical



  • Manufacturer: FOUGERA PHARMS

    Approval date: December 29, 2004

    Strength(s): 0.77% [AB]


  • Manufacturer: G AND W LABS INC

    Approval date: December 20, 2010

    Strength(s): 0.77% [AB]


  • Manufacturer: GLENMARK PHARMS

    Approval date: November 10, 2009

    Strength(s): 0.77% [AB]


  • Manufacturer: PERRIGO

    Approval date: March 3, 2006

    Strength(s): 0.77% [AB]


  • Manufacturer: TARO

    Approval date: April 12, 2005

    Strength(s): 0.77% [AB]

ciclopirox gel; topical



  • Manufacturer: FOUGERA PHARMS

    Approval date: June 10, 2008

    Strength(s): 0.77% [AB]


  • Manufacturer: PADDOCK LLC

    Approval date: January 7, 2009

    Strength(s): 0.77% [AB]

ciclopirox shampoo; topical



  • Manufacturer: FOUGERA PHARMS

    Approval date: May 25, 2010

    Strength(s): 1% [AT]


  • Manufacturer: PADDOCK LLC

    Approval date: November 24, 2009

    Strength(s): 1% [AT]


  • Manufacturer: PERRIGO

    Approval date: February 16, 2010

    Strength(s): 1% [AT]


  • Manufacturer: TARO

    Approval date: February 23, 2011

    Strength(s): 1% [AT]

ciclopirox suspension; topical



  • Manufacturer: FOUGERA PHARMS

    Approval date: August 6, 2004

    Strength(s): 0.77% [AB]


  • Manufacturer: PERRIGO NEW YORK

    Approval date: December 15, 2006

    Strength(s): 0.77% [AB]


  • Manufacturer: TARO

    Approval date: August 10, 2005

    Strength(s): 0.77% [AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Loprox. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Antimycotic gel with high active substance release
    Patent 7,018,656
    Issued: March 28, 2006
    Inventor(s): Bohn; Manfred & Kraemer; Karl Theodor & Markus; Astrid
    Assignee(s): Aventis Pharma Deutschland GmbH
    A pharmaceutical preparation comprising a hydrophilic gel-forming agent, water and a compound of the formula I is suitable for the treatment and prophylaxis of dermatomycoses.
    Patent expiration dates:

    • September 5, 2018
      ✓ 
      Drug product




  • Antimycotic gel having high active compound release
    Patent 7,026,337
    Issued: April 11, 2006
    Inventor(s): Bohn; Manfred & Kraemer; Karl Theodor & Markus; Astrid
    Assignee(s): Aventis Pharma Deutschland GmbH
    A pharmaceutical preparation comprising a hydrophilic gel-forming agent, water and a compound of the formula I is suitable for the treatment and prophylaxis of dermatomycoses.
    Patent expiration dates:

    • November 21, 2016
      ✓ 
      Patent use: TOPICAL TREATMENT OF INTERDIGITAL TINEA PEDIS AND TINEA CORPORIS DUE TO TRICHOPHYTON RUBRUM, TRICHOPHYTON MENTAGROPHYTES OR EPIDERMOPHYTON FLOCCOSUM




  • Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis
    Patent 7,981,909
    Issued: July 19, 2011
    Inventor(s): Bohn; Manfred & Kraemer; Karl Theodor & Markus; Astrid
    Assignee(s): Medicis Pharmaceutical Corporation
    Compounds of the formula (I) are disclosed and are suitable for the treatment of seborrheic dermatitis.
    Patent expiration dates:

    • September 16, 2017
      ✓ 
      Patent use: TREATMENT OF SEBORRHEIC DERMATITIS OF THE SCALP



See also...

  • Loprox Cream Consumer Information (Wolters Kluwer)
  • Loprox Gel Consumer Information (Wolters Kluwer)
  • Loprox Shampoo Consumer Information (Wolters Kluwer)
  • Loprox Suspension Consumer Information (Wolters Kluwer)
  • Loprox Consumer Information (Cerner Multum)
  • Loprox Topical Advanced Consumer Information (Micromedex)
  • Ciclopirox Cream Consumer Information (Wolters Kluwer)
  • Ciclopirox Gel Consumer Information (Wolters Kluwer)
  • Ciclopirox Shampoo Consumer Information (Wolters Kluwer)
  • Ciclopirox Solution Consumer Information (Wolters Kluwer)
  • Ciclopirox Solution Kit Consumer Information (Wolters Kluwer)
  • Ciclopirox Suspension Consumer Information (Wolters Kluwer)
  • Ciclopirox topical Consumer Information (Cerner Multum)
  • Ciclopirox Topical Advanced Consumer Information (Micromedex)
  • Ciclopirox Olamine AHFS DI Monographs (ASHP)

Thursday, August 19, 2010

Oxyplastine




Oxyplastine may be available in the countries listed below.


Ingredient matches for Oxyplastine



Zinc Oxide

Zinc Oxide is reported as an ingredient of Oxyplastine in the following countries:


  • France

  • Tunisia

International Drug Name Search

Saturday, August 14, 2010

Bolt B12 + Selenium




Bolt B12 + Selenium may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Bolt B12 + Selenium



Hydroxocobalamin

Hydroxocobalamin acetate (a derivative of Hydroxocobalamin) is reported as an ingredient of Bolt B12 + Selenium in the following countries:


  • New Zealand

Sodium Selenate

Sodium Selenate is reported as an ingredient of Bolt B12 + Selenium in the following countries:


  • New Zealand

International Drug Name Search

Thursday, August 12, 2010

Combicef




Combicef may be available in the countries listed below.


Ingredient matches for Combicef



Cefotaxime

Cefotaxime sodium salt (a derivative of Cefotaxime) is reported as an ingredient of Combicef in the following countries:


  • Indonesia

International Drug Name Search

Amlodipina Northia




Amlodipina Northia may be available in the countries listed below.


Ingredient matches for Amlodipina Northia



Amlodipine

Amlodipine besilate (a derivative of Amlodipine) is reported as an ingredient of Amlodipina Northia in the following countries:


  • Argentina

International Drug Name Search

Monday, August 9, 2010

Insulina Humulin R




Insulina Humulin R may be available in the countries listed below.


Ingredient matches for Insulina Humulin R



Insulin Injection, Soluble

Insulin Injection, Soluble human (a derivative of Insulin Injection, Soluble) is reported as an ingredient of Insulina Humulin R in the following countries:


  • Argentina

  • Chile

International Drug Name Search

Sunday, August 8, 2010

Rekawan




Rekawan may be available in the countries listed below.


Ingredient matches for Rekawan



Potassium Chloride

Potassium Chloride is reported as an ingredient of Rekawan in the following countries:


  • Germany

International Drug Name Search

Thursday, August 5, 2010

Carvedigamma




Carvedigamma may be available in the countries listed below.


Ingredient matches for Carvedigamma



Carvedilol

Carvedilol is reported as an ingredient of Carvedigamma in the following countries:


  • Bulgaria

  • Czech Republic

  • Estonia

  • Germany

  • Hungary

  • Latvia

  • Lithuania

  • Poland

  • Romania

  • Slovakia

  • Slovenia

International Drug Name Search

Tuesday, August 3, 2010

Ektomin




Ektomin may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Ektomin



Cypermethrin

Cypermethrin is reported as an ingredient of Ektomin in the following countries:


  • Switzerland

International Drug Name Search